These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6311309)

  • 1. [Effect of antioxidants of the 3-hydroxypyridine class on cyclic 3', 5'-adenosine monophosphate phosphodiesterase activity].
    Smirnov LD; Malykhina LS; Lazarevich VG; Fedorov NA
    Biull Eksp Biol Med; 1983 Sep; 96(9):40-2. PubMed ID: 6311309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibition of platelet aggregation and cyclic nucleotide phosphodiesterase (specifically cyclAMP) by 3-hydroxypyridine derivatives].
    Kagan VE; Polianskiĭ NB; Muranov KO; Shvedova AA; Smirnov LD
    Biull Eksp Biol Med; 1984 Apr; 97(4):416-8. PubMed ID: 6202339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition by 2- or/and 8-substituted adenosine derivatives of adenosine deaminase and calmodulin-dependent phosphodiesterase.
    Sasaki Y; Ono Y
    Nucleic Acids Symp Ser; 1980; (8):s163-6. PubMed ID: 6265879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibition of rat heart and brain cyclic 3',5'-adenosine monophosphate phosphodiesterase under the influence of neurohormone "C"].
    Galoian AA; Gurvits BIa; Pogosian MA
    Vopr Biokhim Mozga; 1976; 11():89-96. PubMed ID: 203105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibition of cyclic nucleotide phosphodiesterase from rabbit heart by hydroxypyridines].
    Polyansky NB; Smirnov LD; Shvedova AA; Kagan VE; Tkachuk VA
    Vopr Med Khim; 1983; 29(1):123-7. PubMed ID: 6301154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Griseolic acid, an inhibitor of cyclic adenosine 3',5'-monophosphate phosphodiesterase. I. Taxonomy, isolation and characterization.
    Nakagawa F; Okazaki T; Naito A; Iijima Y; Yamazaki M
    J Antibiot (Tokyo); 1985 Jul; 38(7):824-9. PubMed ID: 2993218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trapidil derivatives as potent inhibitors of cyclic AMP phosphodiesterase from heart and coronary arteries.
    Bartel S; Tenor H; Krause EG
    Biomed Biochim Acta; 1985; 44(5):K31-5. PubMed ID: 2415118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic AMP phosphodiesterase inhibition by coumarins and furanocoumarins.
    Sardari S; Nishibe S; Horita K; Nikaido T; Daneshtalab M
    Pharmazie; 1999 Jul; 54(7):554-6. PubMed ID: 10445247
    [No Abstract]   [Full Text] [Related]  

  • 9. Methyl 5'-(6-aminopurin-9-yl)-5'-deoxy-beta-D-ribofuranoside 2',3'-cyclic monophosphate: a novel, biologically active, structural analogue of cyclic AMP.
    Nair V; Wiechert RJ; Vietti DE; Singh D; Stevens RH
    J Cyclic Nucleotide Res; 1980; 6(3):189-200. PubMed ID: 6255019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cyclic AMP phosphodiesterase inhibitors on cardiac sarcolemmal 5'-nucleotidase.
    Heyliger CE; Panagia V; Dhalla NS
    J Pharmacol Exp Ther; 1981 May; 217(2):489-93. PubMed ID: 6262487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic AMP phosphodiesterase from human heart and drug action.
    Tanaka T; Masuoka H; Ito M; Nakano T; Naka M; Hidaka H
    Adv Second Messenger Phosphoprotein Res; 1992; 25():373-81. PubMed ID: 1313268
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of adenosine 3',5'-cyclic monophosphate phosphodiesterase by flavonoids. II.
    Nikaido T; Ohmoto T; Sankawa U; Tomimori T; Miyaichi Y; Imoto Y
    Chem Pharm Bull (Tokyo); 1988 Feb; 36(2):654-61. PubMed ID: 2842074
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential inhibitor effects on cyclic adenosine monophosphate-phosphodiesterase isoforms in atopic and normal leukocytes.
    Chan SC; Hanifin JM
    J Lab Clin Med; 1993 Jan; 121(1):44-51. PubMed ID: 8381148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue and species specificity of cardiac cAMP-phosphodiesterase inhibitors.
    Pang DC
    Adv Second Messenger Phosphoprotein Res; 1992; 25():307-20. PubMed ID: 1313264
    [No Abstract]   [Full Text] [Related]  

  • 15. [The seasonal rhythm of changes in adenosine cyclic monophosphate phosphodiesterase activity in the lymphocytes of human peripheral blood].
    Kochetkova MN; Ozeretskovskaia NN; Ezhkova NG
    Izv Akad Nauk SSSR Biol; 1988; (5):782-5. PubMed ID: 2849615
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of heart and brain cyclic adenosine 3',5'-monophosphate phosphodiesterase by new non-steroidic compounds structurally related to natural cardenolides.
    Nemoz G; Prigent AF; Pacheco H
    Biochem Pharmacol; 1978; 27(24):2769-74. PubMed ID: 216370
    [No Abstract]   [Full Text] [Related]  

  • 17. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of adenosine 3',5'-cyclic monophosphate phosphodiesterase by nicotinic acid [proceedings].
    Saeed SA; Butt NM; Lovely JR; Collier HO
    Biochem Soc Trans; 1979 Oct; 7(5):1042-4. PubMed ID: 229022
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibitors of adenosine 3',5'-cyclic monophosphate phosphodiesterase in Daphne genkwa Sieb. et Zucc.
    Nikaido T; Ohmoto T; Sankawa U
    Chem Pharm Bull (Tokyo); 1987 Feb; 35(2):675-81. PubMed ID: 3036384
    [No Abstract]   [Full Text] [Related]  

  • 20. Silymarin: potent inhibitor of cyclic AMP phosphodiesterase.
    Koch HP; Bachner J; Löffler E
    Methods Find Exp Clin Pharmacol; 1985 Aug; 7(8):409-13. PubMed ID: 3001454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.